Addus HomeCare (NASDAQ:ADUS) Downgraded by Wall Street Zen to “Buy”

Wall Street Zen downgraded shares of Addus HomeCare (NASDAQ:ADUS) from a strong-buy rating to a buy rating in a research report report published on Saturday morning.

Several other equities research analysts also recently commented on the company. Truist Financial set a $135.00 price objective on Addus HomeCare and gave the stock a “buy” rating in a report on Wednesday, January 7th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, January 21st. Barclays reduced their price target on shares of Addus HomeCare from $117.00 to $112.00 and set an “underweight” rating for the company in a research note on Tuesday, February 24th. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a report on Wednesday, February 25th. Finally, Royal Bank Of Canada restated an “outperform” rating and issued a $139.00 target price on shares of Addus HomeCare in a report on Wednesday, February 25th. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $134.33.

Addus HomeCare Stock Down 0.7%

Addus HomeCare stock opened at $99.28 on Friday. Addus HomeCare has a 12 month low of $88.96 and a 12 month high of $124.43. The stock has a fifty day simple moving average of $106.90 and a two-hundred day simple moving average of $111.59. The company has a current ratio of 1.80, a quick ratio of 1.80 and a debt-to-equity ratio of 0.11. The firm has a market cap of $1.85 billion, a price-to-earnings ratio of 19.06, a PEG ratio of 1.38 and a beta of 0.92.

Insider Buying and Selling at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 300 shares of Addus HomeCare stock in a transaction that occurred on Wednesday, February 25th. The stock was sold at an average price of $105.36, for a total transaction of $31,608.00. Following the sale, the executive vice president owned 9,444 shares of the company’s stock, valued at approximately $995,019.84. This trade represents a 3.08% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP David W. Tucker sold 379 shares of Addus HomeCare stock in a transaction on Wednesday, February 25th. The shares were sold at an average price of $105.36, for a total transaction of $39,931.44. Following the completion of the sale, the executive vice president owned 10,423 shares in the company, valued at approximately $1,098,167.28. This represents a 3.51% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last quarter, insiders sold 16,610 shares of company stock valued at $1,768,970. 4.50% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Addus HomeCare

A number of hedge funds have recently made changes to their positions in the company. Global Retirement Partners LLC boosted its stake in Addus HomeCare by 395.7% during the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock valued at $25,000 after buying an additional 186 shares during the last quarter. Larson Financial Group LLC raised its holdings in shares of Addus HomeCare by 133.3% during the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after acquiring an additional 136 shares in the last quarter. Acumen Wealth Advisors LLC purchased a new stake in shares of Addus HomeCare during the 4th quarter worth approximately $29,000. Private Trust Co. NA boosted its position in shares of Addus HomeCare by 65.5% during the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock valued at $30,000 after acquiring an additional 112 shares during the last quarter. Finally, Arax Advisory Partners boosted its position in shares of Addus HomeCare by 95.8% during the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after acquiring an additional 137 shares during the last quarter. 95.35% of the stock is currently owned by hedge funds and other institutional investors.

Addus HomeCare Company Profile

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.